← Back to Search

Education Program for Breast Cancer Screening

N/A

Recruiting

Led By Heather Hurwitz, PhD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women under age 40 who present with high risk breast cancer related symptoms or a first degree relative with breast cancer

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at intervention, an average of 30 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing ways to improve breast cancer screening and care for homeless women, who are at high risk for the disease.

Who is the study for?

This trial is for women under 40 at high risk of breast cancer who haven't had a mammogram in the last year and are staying in homeless shelters or transitional housing in Cleveland. It's not open to those outside this area.

What is being tested?

The study tests if education sessions and surveys can help increase breast cancer screening rates among homeless women, aiming to catch cancer earlier.

What are the potential side effects?

Since the interventions involve educational sessions and surveys, there aren't direct medical side effects; however, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman under 40 with high risk breast cancer symptoms or a family history.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at intervention, an average of 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at intervention, an average of 30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and at intervention, an average of 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of women agreeing to outreach educational program

Secondary study objectives

Baseline mammogram screening rate

Prevalence of social barriers to cancer screening

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Outreach educational programExperimental Treatment2 Interventions

Participants will be given a survey to elucidate beliefs and barriers around breast health and mammography. A brief, culturally-appropriate educational session about breast health and mammography will follow and will be delivered by a female public health educator. After education, eligible women will be offered a free on-site mammogram

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Education Session

2018

N/A

~30

0 / 1Eligibility criteria met